Stock Comparison
JNJ vs MRK
Johnson & Johnson and Merck & Company Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$613.02B
$317.77B
P/E (TTM)
29.5
36.2
Forward P/E
22.0
25.5
Price/Sales
6.4
4.8
Price/Book
7.6
6.9
EV/EBITDA
19.2
18.6
Dividend Yield
2.12%
2.61%
Profitability
Net Margin
21.80%
13.60%
Operating Margin
27.40%
38.60%
Return on Equity
26.40%
18.90%
Return on Assets
8.42%
12.60%
Growth (YoY)
Revenue Growth
9.90%
4.90%
Earnings Growth
-52.90%
-19.30%
Price & Risk
Beta
0.3
0.2
52-Week High
$255.11
$128.78
52-Week Low
$147.81
$74.18
Analyst Target
$257.32
$130.39
Compare JNJ and MRK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.